From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents / Q000600:supply & distribution; D053626:Atovaquone; D002644:Chickenpox; D002648:Child; D000075202:Contraindications; D004348:Drug Labeling; D015507:Drugs, Investigational / Q000600:supply & distribution*; D006801:Humans; D008297:Male; D009285:Naphthoquinones / Q000600:supply & distribution; D004366:Nonprescription Drugs; D010074:Oxandrolone / Q000600:supply & distribution; D013619:Tacrine / Q000600:supply & distribution; D014481:United States; D014486:United States Food and Drug Administration; D015431:Weight Loss
D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents; D015507:Drugs, Investigational; D009285:Naphthoquinones; D004366:Nonprescription Drugs; D013619:Tacrine; D010074:Oxandrolone; D053626:Atovaquone